Chlordiazepoxide-clidinium is a combination prescription medication that pairs two active ingredients to treat digestive conditions where both physical symptoms and stress-related factors play a role. Sold under the brand name Librax, it combines a benzodiazepine (chlordiazepoxide) with an anticholinergic (clidinium bromide). It’s primarily prescribed for irritable bowel syndrome, peptic ulcers, and acute intestinal inflammation.
What It Treats
This combination is FDA-approved to control what the label describes as “emotional and somatic factors in gastrointestinal disorders.” In practical terms, that means it targets gut conditions where anxiety or emotional stress worsens physical symptoms like cramping, spasms, and excess stomach acid. The specific conditions it’s used for include irritable bowel syndrome (sometimes called spastic colon or mucous colitis), peptic ulcers, and acute enterocolitis, which is inflammation of the intestines. For peptic ulcers, it’s typically used alongside other treatments rather than as a standalone therapy.
How the Two Ingredients Work Together
The two components address different parts of the problem. Chlordiazepoxide is a benzodiazepine, meaning it slows activity in the central nervous system. This produces a calming effect that reduces the anxiety and emotional tension that can trigger or worsen gut symptoms. Clidinium is an anticholinergic agent. It works directly on the digestive tract by reducing stomach acid production and decreasing bowel spasms. Together, one ingredient quiets the nervous system’s overreaction while the other physically relaxes the gut.
Who Should Not Take It
Chlordiazepoxide-clidinium is contraindicated for people with glaucoma because the anticholinergic component can dilate the pupils, potentially increasing eye pressure. It’s also off-limits for anyone with an enlarged prostate or a bladder neck obstruction that causes difficulty urinating. The anticholinergic effects can make these urinary conditions significantly worse.
Older adults face particular risks with this medication. Benzodiazepines are associated with confusion, cognitive impairment, and delirium in people over 65. Anticholinergics carry similar concerns in this age group. A medication that combines both classes demands extra caution.
Common Side Effects
Because this drug contains both a sedative and an anticholinergic, side effects tend to come from both directions. From the benzodiazepine component, you can expect drowsiness, fatigue, and sometimes mental fogginess. From the anticholinergic side, dry mouth, blurred vision, constipation, and difficulty urinating are typical. These effects are usually more pronounced when you first start taking the medication and may lessen over time.
Alcohol intensifies the sedative effects of the benzodiazepine component, so mixing the two can cause dangerous levels of drowsiness and impaired coordination. The same applies to opioid pain medications and other drugs that depress the central nervous system.
Dependence and Withdrawal Risk
Chlordiazepoxide is classified as a Schedule IV controlled substance by the DEA, meaning it has a recognized potential for abuse and addiction. Physical dependence can develop with continued use. The risk increases with higher doses and longer treatment duration. This doesn’t mean everyone who takes it becomes dependent, but it’s a real consideration, especially for a condition like IBS that can be chronic.
Stopping the medication abruptly after regular use can trigger withdrawal symptoms. The body adapts to the presence of the benzodiazepine over time, and removing it suddenly forces a readjustment that can be uncomfortable or, in some cases, dangerous. For this reason, the dose is typically reduced gradually rather than stopped all at once. If you’ve been taking chlordiazepoxide-clidinium for more than a few weeks, your prescriber will likely outline a tapering schedule when it’s time to discontinue.
How It Compares to Other IBS Treatments
Chlordiazepoxide-clidinium has been available since the 1960s, which makes it one of the older options for IBS. Modern treatment for irritable bowel syndrome often relies on antispasmodics without the benzodiazepine component, or on newer classes of medications that target gut motility more specifically. The inclusion of a benzodiazepine makes Librax effective for people whose gut symptoms are tightly linked to anxiety, but it also introduces risks (dependence, sedation, cognitive effects) that many newer options avoid. It’s generally considered a short-term tool rather than a long-term management strategy for chronic digestive conditions.